Autonomix Medical Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Autonomix Medical, Inc. (AMIX) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022
Period EndingDec 2025Mar 2024Mar 2023Mar 2022
Operating Activities
Net Income-11.41-15.43-1.99-13.33
Depreciation & Amortization0.180.080.000.00
Stock Based Compensation1.630.620.0013.17
Change in Working Capital1.240.080.140.20
Change in Accounts Payable0.180.320.080.09
Change in Other Working Capital1.06-0.240.060.12
Other Operating Activities0.108.000.00-0.48
Net Cash from Operating Activities-8.26-6.65-1.85-0.39
Investing Activities
Capital Expenditures-0.01-0.020.000.00
Net Cash from Investing Activities-0.01-0.020.000.00
Financing Activities
Common Stock Issued10.0313.710.682.00
Other Financing Activities-1.23-1.300.00-0.11
Net Cash from Financing Activities8.8014.410.682.43
Summary
Net Change in Cash0.537.74-1.182.04
Cash at Beginning of Period8.610.872.040.00
Cash at End of Period9.148.610.870.00
Free Cash Flow-8.27-6.67-1.85-0.39